Evidence map›Paper›PMID 36823229›Full record

ArticleVirchows Archiv : an international journal of pathology2023

The devil is in the details: a small-lesion sensitive weakly supervised learning framework for prostate cancer detection and grading.

Zhongyi Yang, Xiyue Wang, Jinxi Xiang, Jun Zhang, Sen Yang, Xinran Wang, Wei Yang, Zhongyu Li, Xiao Han, Yueping Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhongyi Yang *School of Software Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Xiyue Wang *College of Computer Science, Sichuan University, Chengdu, Sichuan, China.
Jinxi Xiang *Tencent AI Lab, Shenzhen, Guangdong, China.
Jun ZhangTencent AI Lab, Shenzhen, Guangdong, China. xdzhangjun@gmail.com.ORCID http://orcid.org/0000-0001-5579-7094
Sen YangTencent AI Lab, Shenzhen, Guangdong, China.
Xinran WangDepartment of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Wei YangTencent AI Lab, Shenzhen, Guangdong, China.
Zhongyu LiSchool of Software Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, China. zhongyuli@xjtu.edu.cn.
Xiao HanTencent AI Lab, Shenzhen, Guangdong, China.
Yueping LiuDepartment of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. annama@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (PCa) is a significant health concern in aging males, and the diagnosis depends primarily on histopathological assessments to determine tumor size and Gleason score. This process is highly time-consuming, subjective, and relies on the extensive experience of the pathologists. Deep learning based artificial intelligence shows an ability to match pathologists on many prostate cancer diagnostic scenarios. However, it is easy to make mistakes on some hard cases with small tumor areas considering the extensively high-resolution of whole slide images (WSIs). The absence of fine-grained and large-scale annotations of such small tumor lesions makes this problem more challenging. Existing methods usually perform uniform cropping of the foreground of WSI and then use convolutional neural networks as the backbone network to predict the classification results. However, cropping can damage the structure of tiny tumors, which affects classification accuracy. To solve this problem, we propose an Intensive-Sampling Multiple Instance Learning Framework (ISMIL), which focuses on tumor regions and improves the recognition of small tumor regions by intensively sampling the crucial regions. Experiments of prostate cancer detection show that our method achieves an area under the receiver operating characteristic curve (AUC) of 0.987 on the PANDA sets, which improves recall by at least 33% with higher specificity over the current primary methods for hard cases. The ISMIL also demonstrates comparable abilities to human experts on the prostate cancer grading task. Moreover, ISMIL has shown good robustness in independent cohorts, which makes it a potential tool to improve the diagnostic efficiency of pathologists.

Indexed as

Artificial IntelligenceProstatic NeoplasmsHumansMaleNeoplasm GradingNeural Networks, ComputerProstateSupervised Machine LearningClassificationComputational pathologyDeep learningProstate cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.